Azenta (AZTA) Projected to Release Quarterly Earnings on Tuesday

Key Points

• Azenta is expected to report Q4 2026 earnings after the market closes Tuesday, November 10. Analysts project earnings of $0.111 per share on revenue of $160.21 million, with the conference call scheduled for November 11.
• In its prior quarter, Azenta reported $0.16 EPS and $161.18 million in revenue, beating analyst estimates of $0.11 EPS and $149.31 million in revenue.
• Azenta shares recently rose 4.5% to $37.16, while analysts’ average rating remains “Hold” with a consensus price target of $41.20.

Azenta (NASDAQ:AZTA - Get Free Report) is projected to release its Q4 2026 results after the market closes on Tuesday, November 10th. Analysts expect the company to announce earnings of $0.1110 per share and revenue of $160.21 million for the quarter. Interested persons may review the information on the company's upcoming Q4 2026 earnings report for the latest details on the call scheduled for Wednesday, November 11, 2026 at 8:30 AM ET.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.11 by $0.05. The firm had revenue of $161.18 million during the quarter, compared to analysts' expectations of $149.31 million. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%.

Azenta Trading Up 4.5%

Shares of Azenta stock traded up $1.61 during trading on Tuesday, hitting $37.16. 343,556 shares of the stock were exchanged, compared to its average volume of 937,958. The company has a fifty day moving average price of $34.93 and a 200-day moving average price of $28.50. The stock has a market capitalization of $1.63 billion, a price-to-earnings ratio of -13.44 and a beta of 1.52. Azenta has a 1-year low of $15.93 and a 1-year high of $46.41.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on AZTA shares. Weiss Ratings upgraded Azenta from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, August 26th. Needham & Company LLC restated a "buy" rating and issued a $37.00 price objective on shares of Azenta in a research note on Monday, September 14th. Finally, Wall Street Zen cut Azenta from a "buy" rating to a "hold" rating in a research report on Sunday, October 18th. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $41.20.

Azenta Company Profile

Azenta, Inc is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical, biotechnology, academic, and clinical research organizations throughout the sample lifecycle, from collection and processing to long-term storage and retrieval.

The company's portfolio includes automated and ultra-low-temperature sample storage systems, laboratory automation equipment, consumables, and software for sample tracking and management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.